[Relationship between parathormone concentration during surgery and the post-operative outcome of primary hyperparathyroidism]

Cir Esp. 2011 Jun-Jul;89(6):386-91. doi: 10.1016/j.ciresp.2011.02.007. Epub 2011 Apr 8.
[Article in Spanish]

Abstract

Introduction: The relationship between the intra-operative concentration of parathyroid hormone (IOPTH) and the long-term outcome of patients intervened due to primary hyperparathyroidism (PHPT).

Patients and methods: A prospective observational study was performed with 120 patients. Three determinations were made of PTH in blood: baseline, when the diseases gland was located, and 10 minutes after its extirpation. The calcium, PTH and vitamin D (25-OH-D3) levels were measured during follow up.

Results: A decrease in IOPTH > 50% was observed in 96 (80%) patients, and the post-extirpation value returned to the normal range (Group I), in 18 (15%) a decrease of > 50% but the final value remained higher than normal (Group II) and in 6 (5%) the decrease was<50% (Group III). Persistent PHPT was detected during follow up in 6 patients (5%): one in Group I (1%), 3 (16.7%) in II and 2 (33.3%) in group III (P<.001). The risk of persistent PHPT was higher in Group II (odds ratio: 19; 95% CI: 1.85-194) and in Group III (odds ratio: 47; 95% CI: 3.53-639). There were no cases of recurrent PHPT. A normal calcium with an increased PTH was detected in 20 patients of Group I (20.8%), 11 (61.1%) in II and 3 (50%) in III (P<.001). These patients had a lower concentration of post-operative vitamin D (17 ng/ml, range: 24; compared to 28 ng/ml, range: 21) (P=.008) and higher frequency of hypovitaminosis D (70.6% compared to 26.2%) (P>.001).

Conclusion: The risk of persistent PHPT is higher when the IOPTH decreases more than 50% but still remains high.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Female
  • Humans
  • Hyperparathyroidism, Primary / blood*
  • Hyperparathyroidism, Primary / surgery*
  • Intraoperative Period
  • Male
  • Middle Aged
  • Parathyroid Hormone / blood*
  • Postoperative Period
  • Prospective Studies
  • Time Factors
  • Treatment Outcome

Substances

  • Parathyroid Hormone